3 grants submitted this month to support our effort 🎯 quiescent cancer cells in #bcsm!
Great work Maia Homsi and Vittal Kurisetty! @AmericanCancer@theNCI@SKabrajiMD
Perfect place for #AACR24. On Wednesday come hear about our ongoing work dissecting residual disease in #HER2+ #bcsm@RoswellPark 6939 - Residual disease after HER2 inhibition is driven by a primary tumor subpopulation expressing an ERBB2-low associated transcriptional program
Introducing lab members Dr Vittal Kurisetty, HRI scientist (left), and Maia Homsi, research technologist (middle), running the first #CyCIF experiment in @KabrajiLab with @SKabrajiMD trying not to get in the way! @RoswellPark
60 day Progress report:
✅ one foundation LOI submitted
✅ one federal grant submitted
✅ one scientist and one technician starting this week
✅ new collaborators
✅ new mentees
✅ fun!
@SKabrajiMD@RoswellPark@SusanGKomen